ANGO logo

ANGO
Angiodynamic Inc

1,059
Mkt Cap
$424.95M
Volume
1.23M
52W High
$13.99
52W Low
$8.36
PE Ratio
-15.31
ANGO Fundamentals
Price
$10.31
Prev Close
$11.94
Open
$11.23
50D MA
$10.84
Beta
1.08
Avg. Volume
369,931.51
EPS (Annual)
-$0.8321
P/B
2.43
Rev/Employee
$433,330.37
$364.75
Loading...
Loading...
News
all
press releases
AngioDynamics (NASDAQ:ANGO) Issues Quarterly Earnings Results, Beats Estimates By $0.13 EPS
AngioDynamics (NASDAQ:ANGO - Get Free Report) posted its quarterly earnings results on Thursday. The medical instruments supplier reported $0.02 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.11) by $0.13. AngioDynamics had a negative return on equity of...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
AngioDynamics Q3 Earnings Call Highlights
AngioDynamics (NASDAQ:ANGO) reported fiscal 2026 third-quarter results that management described as strong across the board, highlighted by faster growth in its MedTech segment and improved adjusted...
MarketBeat·1d ago
News Placeholder
AngioDynamics (ANGO) Reports Q3 Loss, Tops Revenue Estimates
AngioDynamics (ANGO) delivered earnings and revenue surprises of +33.33% and +1.35%, respectively, for the quarter ended February 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1d ago
News Placeholder
AngioDynamics Reports Fiscal Year 2026 Third Quarter Financial Results; Sustained Double-Digit Med Tech Growth Drives Continued Profitability
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the bodys vascular system, expanding cancer treatment options...
Business Wire·1d ago
News Placeholder
Acuity, Lindsay And 3 Stocks To Watch Heading Into Thursday
U.S. stock futures trading lower, Acuity and Visionary Holdings report strong earnings, Lindsay Corp expected to post earnings, Globalstar shares jump after Amazon acquisition talks, AngioDynamics...
Benzinga·1d ago
News Placeholder
AngioDynamics (NASDAQ:ANGO) Downgraded to Hold Rating by Zacks Research
Zacks Research downgraded AngioDynamics from a "strong-buy" rating to a "hold" rating in a research report on Monday...
MarketBeat·2d ago
News Placeholder
AngioDynamics to Present at the 25th Annual Needham Virtual Healthcare Conference
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the bodys vascular system, expanding cancer treatment options...
Business Wire·3d ago
News Placeholder
Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Decreases By 18.0%
AngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) was the target of a significant decline in short interest in March. As of March 13th, there was short interest totaling 1,784,550 shares, a decline...
MarketBeat·5d ago
News Placeholder
AngioDynamics, Inc. (NASDAQ:ANGO) Receives Average Recommendation of "Moderate Buy" from Brokerages
AngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) has earned a consensus rating of "Moderate Buy" from the five brokerages that are covering the company, Marketbeat Ratings reports. One equities...
MarketBeat·6d ago
News Placeholder
AngioDynamics (ANGO) Expected to Announce Quarterly Earnings on Thursday
AngioDynamics (NASDAQ:ANGO) will be releasing its Q3 2026 earnings before the market opens on Thursday, April 2. (View Earnings Report at...
MarketBeat·9d ago
<
1
2
...
>

Latest ANGO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.